In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fluxum Drug Master File in Korea (Fluxum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fluxum. The MFDS reviews the Fluxum KDMF as part of the drug registration process and uses the information provided in the Fluxum KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fluxum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fluxum API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fluxum suppliers with KDMF on PharmaCompass.